Company Filing History:
Years Active: 1998
Title: Stewart E. Hartkopf: Innovator in Pharmaceutical Recordkeeping Systems
Introduction
Stewart E. Hartkopf is a notable inventor based in Cherry Hill, NJ (US), recognized for his contributions to pharmaceutical recordkeeping systems. With a total of two patents to his name, Hartkopf has made significant strides in improving the efficiency and accuracy of manufacturing processes in the pharmaceutical industry.
Latest Patents
Hartkopf's latest patents include a "Pharmaceutical Recordkeeping System with Labelling for Manufacturing Raw" and a "Pharmaceutical Recordkeeping System." The first patent describes a comprehensive system for recordkeeping that involves assigning a bar code label to materials being processed. This system includes reading the bar code at various processing stations, assigning additional labels that contain information about processing operations, and storing all relevant data in a main storage device. The second patent outlines a method for recordkeeping that utilizes serialized portable memory devices assigned to individual lots of material. This method ensures that identification and requirements data are accurately recorded and transferred throughout the manufacturing process.
Career Highlights
Stewart E. Hartkopf is currently employed at Base Ten Systems, Inc., where he continues to develop innovative solutions for the pharmaceutical industry. His work focuses on enhancing recordkeeping methods to ensure compliance and improve operational efficiency.
Collaborations
Hartkopf has collaborated with notable colleagues, including Joel E. Medeiros and Louis M. Gaburo, contributing to a dynamic work environment that fosters innovation and creativity.
Conclusion
Stewart E. Hartkopf's contributions to pharmaceutical recordkeeping systems exemplify his commitment to innovation in the industry. His patents reflect a deep understanding of the complexities involved in manufacturing processes, making him a valuable asset to Base Ten Systems, Inc. and the broader pharmaceutical community.